Bacterial vaginosis Infections and Infestations Bacterial vaginosis
Conditions
Interventions
Intervention group:
Clindamycin (7 days) and EcoVag for four menstrual periods. EcoVag was administered for 5 to 10 days in the first menstrual period and for 10 days during each of the subsequent 3
Sponsors
Bifodan A/S (Denmark)
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Non-pregnant female between 18 and 60 years of age with regular menstrual period fulfilling Amsel criteria for bacterial vaginosis
Exclusion criteria
Exclusion criteria: 1. Ongoing infection with candida albicans or clamydia trachomatis 2. Participating in another drug study within the last 6 weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time from healing to relapse of symptoms, measured after one month, three and six months after treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of patients initially healed, measured after one month, three and six months after treatment. | — |
Countries
Norway
Outcome results
None listed